Search Results - "Støer, Nathalie"

Refine Results
  1. 1

    Downstaging and survival after Neoadjuvant chemotherapy for bladder cancer in Norway; a population-based study by Møller, Christina Tanem, Støer, Nathalie C, Blindheim, Augun, Berge, Viktor, Tafjord, Gunnar, Fosså, Sophie D, Andreassen, Bettina Kulle

    Published in BMC cancer (12-12-2022)
    “…Neoadjuvant chemotherapy (NAC) before radical cystectomy is associated with pathological downstaging (DS) and improved overall survival (OS) in patients with…”
    Get full text
    Journal Article
  2. 2

    Cancer epidemiology in practice: Working notes on cancer history-based selection and censoring by Berge, Leon A.M., Grimsrud, Tom K., Babigumira, Ronnie, Støer, Nathalie C., Shala, Nita K., Veierød, Marit B., Stenehjem, Jo S.

    Published in Norsk epidemiologi (12-10-2022)
    “…Leon A.M. Berge, Tom K. Grimsrud, Ronnie Babigumira, Nathalie C. Støer, Nita K. Shala, Marit B. Veierød and Jo S. Stenehjem: Cancer epidemiology in practice:…”
    Get full text
    Journal Article
  3. 3
  4. 4

    A New Procedure to Assess When Estimates from the Cumulative Link Model Can Be Interpreted as Differences for Ordinal Scales in Quality of Life Studies by Ning, Yilin, Ho, Peh Joo, Støer, Nathalie C, Lim, Ka Keat, Wee, Hwee-Lin, Hartman, Mikael, Reilly, Marie, Tan, Chuen Seng

    Published in Clinical epidemiology (2021)
    “…Assessing the clinical importance of an exposure effect on a quality of life (QoL) score often requires quantifying the effect in terms of a difference in…”
    Get full text
    Journal Article
  5. 5

    β-blockers and breast cancer survival by molecular subtypes: a population-based cohort study and meta-analysis by Løfling, L. Lukas, Støer, Nathalie C., Sloan, Erica K., Chang, Aeson, Gandini, Sara, Ursin, Giske, Botteri, Edoardo

    Published in British journal of cancer (05-10-2022)
    “…Background The association between use of β-blockers and breast cancer (BC) prognosis has been investigated in several observational studies, with conflicting…”
    Get full text
    Journal Article
  6. 6

    Menopausal hormone therapy and risk of melanoma: Do estrogens and progestins have a different role? by Botteri, Edoardo, Støer, Nathalie C., Sakshaug, Solveig, Graff‐Iversen, Sidsel, Vangen, Siri, Hofvind, Solveig, Ursin, Giske, Weiderpass, Elisabete

    Published in International journal of cancer (01-11-2017)
    “…The association between use of menopausal hormone therapy (HT) and occurrence of skin malignant melanoma (SMM) is controversial. We investigated the issue in a…”
    Get full text
    Journal Article
  7. 7

    Low-dose aspirin and risk of breast cancer: a Norwegian population-based cohort study of one million women by Løfling, Lukas, Støer, Nathalie C., Nafisi, Sara, Ursin, Giske, Hofvind, Solveig, Botteri, Edoardo

    Published in European journal of epidemiology (01-04-2023)
    “…Several studies evaluated the association between aspirin use and risk of breast cancer (BC), with inconsistent results. We identified women aged ≥ 50 years…”
    Get full text
    Journal Article
  8. 8

    Menopausal hormone therapy and breast cancer risk: a population-based cohort study of 1.3 million women in Norway by Støer, Nathalie C., Vangen, Siri, Singh, Deependra, Fortner, Renée T., Hofvind, Solveig, Ursin, Giske, Botteri, Edoardo

    Published in British journal of cancer (27-07-2024)
    “…Background It is important to monitor the association between menopausal hormone therapy (HT) use and breast cancer (BC) risk with contemporary estimates, and…”
    Get full text
    Journal Article
  9. 9

    Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study by Löfling, L. Lukas, Staer, Nathalie C, Andreassen, Bettina Kulle, Ursin, Giske, Botteri, Edoardo

    Published in Breast cancer research : BCR (30-08-2023)
    “…Background Previous studies assessed the prognostic effect of aspirin, statins, and metformin in breast cancer (BC) patients, with inconclusive results…”
    Get full text
    Journal Article
  10. 10

    Real-world effectiveness of HPV vaccination against cervical neoplasia among birth cohorts ineligible for routine vaccination by Dong, Li, Nygård, Mari, Støer, Nathalie C, Klungsøyr, Ole, Hansen, Bo T

    Published in International journal of cancer (15-07-2023)
    “…Human papillomavirus (HPV) vaccine effectiveness may differ between settings. Here we present the first real-world effectiveness study of HPV vaccination on…”
    Get full text
    Journal Article
  11. 11

    Menopausal Hormone Therapy and Risk of Melanoma: A Nationwide Register-Based Study in Finland by Botteri, Edoardo, Støer, Nathalie C, Weiderpass, Elisabete, Pukkala, Eero, Ylikorkala, Olavi, Lyytinen, Heli

    “…The association between use of menopausal hormone therapy and risk of cutaneous melanoma is highly debated. We investigated the issue in a Finnish nationwide…”
    Get full text
    Journal Article
  12. 12

    Menopausal hormone therapy and melanoma risk in the Australian longitudinal study on women's health by Botteri, Edoardo, Xu, Zhiwei, Støer, Nathalie C., Mishra, Gita D.

    Published in Maturitas (01-06-2022)
    “…•New evidence is linking use of menopausal hormone therapy to risk of melanoma.•We used data from 18,850 women in the Australian Longitudinal Study on Women's…”
    Get full text
    Journal Article
  13. 13

    Antimuscarinics and lung cancer survival: A Norwegian population-based cohort study by Sanjinez, Claudia, Botteri, Edoardo, Støer, Nathalie C, Lukas Löfling, L

    Published in Lung cancer (Amsterdam, Netherlands) (01-05-2023)
    “…•Preclinical studies suggest a possible role of antimuscarinics in lung cancer prognosis.•We found an association between post-diagnostic use and prolonged…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Psychological effect of cervical cancer screening when changing primary screening method from cytology to high‐risk human papilloma virus testing by Andreassen, Trude, Hansen, Bo T., Engesæter, Birgit, Hashim, Dana, Støer, Nathalie C., Tropé, Ameli, Moen, Kåre, Ursin, Giske, Weiderpass, Elisabete

    Published in International journal of cancer (01-07-2019)
    “…From 2015, Norway has implemented high‐risk human papilloma virus (hrHPV) testing in primary screening for cervical cancer. Women aged 34–69 years, living in…”
    Get full text
    Journal Article
  16. 16

    HPV Testing for Cervical Cancer in Romania: High-Risk HPV Prevalence among Ethnic Subpopulations and Regions by Ilisiu, Minodora Bianca, Hashim, Dana, Andreassen, Trude, Støer, Nathalie C, Nicula, Florian, Weiderpass, Elisabete

    Published in Annals of global health (20-06-2019)
    “…Romania has had one of the highest rates of cervical cancer incidence and mortality in Europe for decades. Data on the high-risk human papillomavirus (hrHPV)…”
    Get full text
    Journal Article
  17. 17

    Prediagnostic serum 25-hydroxyvitamin D and melanoma risk by Stenehjem, Jo S., Støer, Nathalie C., Ghiasvand, Reza, Grimsrud, Tom K., Babigumira, Ronnie, Rees, Judy R., Nilsen, Lill Tove, Johnsen, Bjørn, Thorsby, Per M., Veierød, Marit B., Robsahm, Trude E.

    Published in Scientific reports (18-11-2020)
    “…Previous studies of serum 25-hydroxyvitamin D (25(OH)D) in relation to melanoma have shown conflicting results. We conducted a nested case–control study of 708…”
    Get full text
    Journal Article
  18. 18

    Use of non-cancer drugs and survival among patients with pancreatic adenocarcinoma: a nationwide registry-based study in Norway by Støer, Nathalie C, Bouche, Gauthier, Pantziarka, Pan, Sloan, Erica K, Andreassen, Bettina K, Botteri, Edoardo

    Published in Acta oncologica (02-09-2021)
    “…The prognosis of pancreatic cancer is poor and new treatment strategies are urgently needed. To identify non-cancer drugs that could be re-purposed for cancer,…”
    Get more information
    Journal Article
  19. 19

    Self-reported Memory Problems 8 Months After COVID-19 Infection by Søraas, Arne, Bø, Ragnhild, Kalleberg, Karl Trygve, Støer, Nathalie C., Ellingjord-Dale, Merete, Landrø, Nils Inge

    Published in JAMA network open (29-07-2021)
    “…COVID-19 is an airway disease that also affects the nervous system.1 Therefore, neurological and neurocognitive symptoms may be a part of the postacute…”
    Get full text
    Journal Article
  20. 20